Patents by Inventor R. C. Warrington

R. C. Warrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition containing propargylamine for enhancing cancer therapy
    Patent number: 6809120
    Abstract: Antineoplastic drug modulators are described. The specific modulators referred to are propargylamines which can enhance the cytotoxic effects of antineoplastic drugs on cancer cells while protecting normal cells from damage. The propargylamine modulators can be used to increase the selectivity and effectiveness of conventional antineoplastic drugs, to reduce the unwanted side-effects of cancer chemotherapy, to improve effectiveness of cancer chemotherapy, to improve treatment of cancers for which treatment is otherwise ineffective, to improve therapy of cancers otherwise unresponsive or poorly responsive due to drug-resistance and/or toxicity limited treatment regimens and to render effective chemotherapy for previously untreatable cancers.
    Type: Grant
    Filed: April 10, 2002
    Date of Patent: October 26, 2004
    Assignee: University of Saskatchewan Technologies Inc.
    Inventors: R. C. Warrington, I. Alick Paterson, Alan A. Boulton